- VernacularTitle:TSC2基因突变致多器官受累的结节性硬化症一例
- Author:
Hongli ZHANG
1
;
Jiayuan DAI
2
;
Yan WANG
3
;
Weihong ZHANG
4
;
Wenbin MA
5
;
Hanhui FU
6
;
Chunxia HE
3
;
Jun ZHENG
7
;
Wenda WANG
8
;
Wei ZUO
9
;
Yaping LIU
10
;
Min SHEN
2
Author Information
- Publication Type:Journal Article
- Keywords: tuberous sclerosis complex; TSC2; multiple organ involvement; genetic testing; multidisciplinary treatment
- From: JOURNAL OF RARE DISEASES 2026;5(1):60-67
- CountryChina
- Language:Chinese
-
Abstract:
Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder primarily caused by pathogenic variants in the
TSC1 orTSC2 genes. It is characterized by multisystem hamartomatous lesions and neuropsychiatric manifestations. Here we report a young male patient with TSC involving multiple organs, caused by a heterozygous frameshift mutation inTSC2 (c.2071delC, p.Arg691Alafs*7). The patient initially presented with classic facial angiofibromas and hypomelanotic macules, and subsequently developed psychiatric and behavioral disturbances with auditory hallucinations. Neuroimaging revealed an intracranial mass lesion, which was confirmed as a subependymal giant cell astrocytoma on postoperative histopathology following surgery performed at an outside institution. After admission, the patient underwent a comprehensive diagnostic workup, and multidisciplinary treatment evaluation revealed extensive multisystem involve-ment, including the nervous system, skin, kidneys, lungs, heart, eyes, pancreas, liver and bones. Combined with relevant literature, this article discusses the molecular mechanisms, clinical phenotypes, and comprehensive management of TSC, in order to provide a reference for the standardized and individualized management of this disease.

